2g/m2 Ara-c induced more favorable outcome than 1g/m2 Ara-c in CLAG treatment for refractory or relapsed acute myeloid leukemia without increase toxicity: a multicenter propensity score matching analysis.
Saved in:
| Title: | 2g/m2 Ara-c induced more favorable outcome than 1g/m2 Ara-c in CLAG treatment for refractory or relapsed acute myeloid leukemia without increase toxicity: a multicenter propensity score matching analysis. |
|---|---|
| Authors: | Liu N; Senior Department of Hematology, Chinese PLA General Hospital, Beijng, China, Beijng, China., Ma YR; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China., Pang JN; Department of Hematology, The First Hospital of Jilin University, Changchun, China., Sun M-; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China., Sun Y; Senior Department of Hematology, Chinese PLA General Hospital, Beijng, China, Beijng, China., Liu YJ; Senior Department of Hematology, Chinese PLA General Hospital, Beijng, China, Beijng, China., Hu JW; Senior Department of Hematology, Chinese PLA General Hospital, Beijng, China, Beijng, China., Li YH; Senior Department of Hematology, Chinese PLA General Hospital, Beijng, China, Beijng, China., Qiao ZQ; Senior Department of Hematology, Chinese PLA General Hospital, Beijng, China, Beijng, China., Duan MH; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. mhduan@sina.com., Gao SJ; Department of Hematology, The First Hospital of Jilin University, Changchun, China. sjgao@jlu.edu.cn., Jiang Q; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China. jiangqian@medmail.com.cn., Hu LD; Senior Department of Hematology, Chinese PLA General Hospital, Beijng, China, Beijng, China. huliangding@sohu.com. |
| Source: | Annals of hematology [Ann Hematol] 2026 Mar 23; Vol. 105 (4). Date of Electronic Publication: 2026 Mar 23. |
| Publication Type: | Journal Article; Multicenter Study; Comparative Study |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41870589 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 2g/m2 Ara-c induced more favorable outcome than 1g/m2 Ara-c in CLAG treatment for refractory or relapsed acute myeloid leukemia without increase toxicity: a multicenter propensity score matching analysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Liu+N%22">Liu N</searchLink>; Senior Department of Hematology, Chinese PLA General Hospital, Beijng, China, Beijng, China.<br /><searchLink fieldCode="AU" term="%22Ma+YR%22">Ma YR</searchLink>; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Pang+JN%22">Pang JN</searchLink>; Department of Hematology, The First Hospital of Jilin University, Changchun, China.<br /><searchLink fieldCode="AU" term="%22Sun+M-%22">Sun M-</searchLink>; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Sun+Y%22">Sun Y</searchLink>; Senior Department of Hematology, Chinese PLA General Hospital, Beijng, China, Beijng, China.<br /><searchLink fieldCode="AU" term="%22Liu+YJ%22">Liu YJ</searchLink>; Senior Department of Hematology, Chinese PLA General Hospital, Beijng, China, Beijng, China.<br /><searchLink fieldCode="AU" term="%22Hu+JW%22">Hu JW</searchLink>; Senior Department of Hematology, Chinese PLA General Hospital, Beijng, China, Beijng, China.<br /><searchLink fieldCode="AU" term="%22Li+YH%22">Li YH</searchLink>; Senior Department of Hematology, Chinese PLA General Hospital, Beijng, China, Beijng, China.<br /><searchLink fieldCode="AU" term="%22Qiao+ZQ%22">Qiao ZQ</searchLink>; Senior Department of Hematology, Chinese PLA General Hospital, Beijng, China, Beijng, China.<br /><searchLink fieldCode="AU" term="%22Duan+MH%22">Duan MH</searchLink>; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. mhduan@sina.com.<br /><searchLink fieldCode="AU" term="%22Gao+SJ%22">Gao SJ</searchLink>; Department of Hematology, The First Hospital of Jilin University, Changchun, China. sjgao@jlu.edu.cn.<br /><searchLink fieldCode="AU" term="%22Jiang+Q%22">Jiang Q</searchLink>; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China. jiangqian@medmail.com.cn.<br /><searchLink fieldCode="AU" term="%22Hu+LD%22">Hu LD</searchLink>; Senior Department of Hematology, Chinese PLA General Hospital, Beijng, China, Beijng, China. huliangding@sohu.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229107334%22">Annals of hematology</searchLink> [Ann Hematol] 2026 Mar 23; Vol. 105 (4). <i>Date of Electronic Publication: </i>2026 Mar 23. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study; Comparative Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>9107334 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0584 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209395555%22">09395555 </searchLink><i>NLM ISO Abbreviation: </i>Ann Hematol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41870589 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00277-026-06913-5 Languages: – Code: eng Text: English Titles: – TitleFull: 2g/m2 Ara-c induced more favorable outcome than 1g/m2 Ara-c in CLAG treatment for refractory or relapsed acute myeloid leukemia without increase toxicity: a multicenter propensity score matching analysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Liu N – PersonEntity: Name: NameFull: Ma YR – PersonEntity: Name: NameFull: Pang JN – PersonEntity: Name: NameFull: Sun M- – PersonEntity: Name: NameFull: Sun Y – PersonEntity: Name: NameFull: Liu YJ – PersonEntity: Name: NameFull: Hu JW – PersonEntity: Name: NameFull: Li YH – PersonEntity: Name: NameFull: Qiao ZQ – PersonEntity: Name: NameFull: Duan MH – PersonEntity: Name: NameFull: Gao SJ – PersonEntity: Name: NameFull: Jiang Q – PersonEntity: Name: NameFull: Hu LD IsPartOfRelationships: – BibEntity: Dates: – D: 23 M: 03 Text: 2026 Mar 23 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1432-0584 Numbering: – Type: volume Value: 105 – Type: issue Value: 4 Titles: – TitleFull: Annals of hematology Type: main |
| ResultId | 1 |